Works by Matthews, Dawn C.

Results: 21

Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease.

Published in:

2021

By:

Matthews, Dawn C;
Mao, Xiangling;
Dowd, Kathleen;
Tsakanikas, Diamanto;
Jiang, Caroline S;
Meuser, Caroline;
Andrews, Randolph D;
Lukic, Ana S;
Lee, Jihyun;
Hampilos, Nicholas;
Shafiian, Neeva;
Sano, Mary;
Mozley, P David;
Fillit, Howard;
McEwen, Bruce S;
Shungu, Dikoma C;
Pereira, Ana C;
David Mozley, P

Publication type:

journal article

Development of a selective estrogen β‐receptor phytoestrogen formulation – PhytoSERM – for the reduction of Alzheimer's risk and relief of menopausal symptoms in women: a phase 2 randomized clinical trial framework.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.080295

By:

Hernandez, Gerson D;
Lopez, Claudia M;
Raikes, Adam C.;
Matthews, Dawn C;
Mosconi, Lisa;
Brinton, Roberta Diaz

Publication type:

Article

Allopregnanolone as a Regenerative Therapeutic for Alzheimer's Disease: Phase 2 proof‐of‐concept clinical trial using hippocampal volume as a surrogate endpoint.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.068251

By:

Hernandez, Gerson D;
Lopez, Claudia M;
Raikes, Adam C.;
Rodgers, Kathleen E.;
Matthews, Dawn C;
Cutter, Gary R;
Schneider, Lon S.;
Brinton, Roberta Diaz

Publication type:

Article

O4‐09‐06: MRI, FDG, AND EARLY FRAME AMYLOID IMAGE CLASSIFIERS TO CHARACTERIZE AND DIFFERENTIATE ALZHEIMER'S DISEASE VARIANTS AND NON‐AD DEMENTIAS.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1429, doi. 10.1016/j.jalz.2018.06.2962

By:

Lukic, Ana S.;
Andrews, Randolph D.;
Bourakova, Viktoriya;
Rabinovici, Gil D.;
Matthews, Dawn C.

Publication type:

Article

P3‐031: THE CRITICAL PATH FOR ALZHEIMER'S DISEASE: HIPPOCAMPAL VOLUME AS AN ENRICHMENT BIOMARKER IN TRIALS OF PATIENTS WITH MILD COGNITIVE IMPAIRMENT.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1076, doi. 10.1016/j.jalz.2018.06.1386

By:

Conrado, Daniela J.;
Nicholas, Timothy;
Burton, Jackson;
Arnerić, Stephen P.;
Chen, Danny;
Stone, Julie A.;
Sinha, Vikram;
Willis, Brian A.;
Kern, Volker D.;
Hill, Derek L.;
Novak, Gerald P.;
Gold, Lisa H.;
Cole, Patricia E.;
Matthews, Dawn C.;
Xie, Zhiyong;
Wang, Wenping;
Hendrix, James;
Wolz, Robin;
Gordon, Mark Forrest;
Romero, Klaus

Publication type:

Article

P1‐380: MRI CLASSIFIERS CHARACTERIZE MILD TRAUMATIC BRAIN INJURY IN SYMPTOMATIC AND PRESYMPTOMATIC STAGES AND DIFFERENTIATE FROM ALZHEIMER'S DISEASE–RELATED IMPAIRMENT.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P443, doi. 10.1016/j.jalz.2018.06.388

By:

Matthews, Dawn C.;
Andrews, Randolph D.;
Lukic, Ana S.;
Mishra, Virendra R.;
Banks, Sarah Jane;
Cummings, Jeffrey L.;
Bernick, Charles

Publication type:

Article

TAU PATHOLOGY ACCUMULATION IS PREDICTED BY A PROGRESSIVE PATTERN OF GLUCOSE HYPOMETABOLISM INITIATING IN PRECLINICAL STAGES.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1101, doi. 10.1016/j.jalz.2017.06.1590

By:

Matthews, Dawn C.;
Andrews, Randolph D.;
Lukic, Ana S.

Publication type:

Article

THE COALITION AGAINST MAJOR DISEASES: TOWARD U.S. FDA QUALIFICATION OF HIPPOCAMPAL VOLUME AS A BIOMARKER FOR ENRICHMENT IN CLINICAL TRIALS FOR PRE-DEMENTIA STAGES OF ALZHEIMER'S DISEASE.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1259, doi. 10.1016/j.jalz.2017.06.1878

By:

Conrado, Daniela J.;
Romero, Klaus;
Corrigan, Brian;
Ito, Kaori;
Nicholas, Timothy;
Chen, Danny;
Samtani, Mahesh N.;
Stone, Julie;
Sinha, Vikram;
Willis, Brian A.;
Kern, Volker D.;
Hill, Derek L.;
Cole, Patricia E.;
Novak, Gerald P.;
Meibach, Richard;
Matthews, Dawn C.;
Schwarz, Adam J.;
Xie, Zhiyong;
Gordon, Mark Forrest;
Arneric, Stephen P.

Publication type:

Article

RELATIONSHIPS BETWEEN TAU BURDEN MEASURED USING AV1451 PET, REGIONAL CEREBRAL GLUCOSE METABOLISM, AND COGNITIVE STATUS.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P1169, doi. 10.1016/j.jalz.2016.07.090

By:

Matthews, Dawn C.;
Andrews, Randolph D.;
Lukic, Ana S.;
Yokoyama, Midori;
Marendic, Boris;
Wernick, Miles N.;
Strother, Stephen C.

Publication type:

Article

COMBINING NEURODEGENERATIVE CHARACTERIZATION WITH AMYLOID BURDEN MEASUREMENT USING AN EARLY FRAME AMYLOID PET MULTIVARIATE CLASSIFIER.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P1082, doi. 10.1016/j.jalz.2016.06.2262

By:

Matthews, Dawn C.;
Lukic, Ana S.;
Andrews, Randolph D.;
Wernick, Miles N.;
Strother, Stephen C.;
Schmidt, Mark E.

Publication type:

Article

MEASUREMENT OF AMYLOID BURDEN USING THE EARLY FRAMES OF AMYLOID PET AND A MULTIVARIATE CLASSIFIER.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P924, doi. 10.1016/j.jalz.2016.06.1913

By:

Matthews, Dawn C.;
Lukic, Ana S.;
Andrews, Randolph D.;
Schmidt, Mark E.;
Wernick, Miles N.;
Strother, Stephen C.

Publication type:

Article

Neurodegenerative variability among amyloid positive MCI patients: Implications for clinical trials and clinical care.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P143, doi. 10.1016/j.jalz.2015.07.066

By:

Matthews, Dawn C.;
Andrews, Randolph D.;
Marendic, Boris;
Yokoyama, Midori;
Lukic, Ana S.

Publication type:

Article

Regional cerebral glucose metabolism provides a sensitive and specific marker of Alzheimer's disease, frontotemporal dementia and mild cognitive impairment, and correlates with cerebrospinal fluid Abeta42 level decline in cognitively normal subjects

Published in:

2010

By:

Matthews, Dawn C.;
Andrews, Randolph D.;
Diehl-Schmid, Janine;
Grafman, Jordan;
Mosconi, Lisa;
de Leon, Mony J.

Publication type:

Abstract

Hippocampal glucose metabolism predicts cognitive decline and correlates to disease progression in the ADNI population

Published in:

2009

By:

Matthews, Dawn C.;
Mosconi, Lisa;
Andrews, Randolph;
Rickert, Karl;
Tsui, Wai H.;
Li, Yi;
Mistur, Rachel;
de Mony Leon, J.

Publication type:

Abstract

Maintaining the Evidence for In Vivo Brain Estrogen Receptor Density by Neuroendocrine Aging and Relationships with Cognition and Symptomatology.

Published in:

2025

By:

Mosconi, Lisa;
Nerattini, Matilde;
Berti, Valentina;
Matthews, Dawn C.;
Andy, Caroline;
Williams, Schantel;
Fink, Matthew;
Pupi, Alberto;
Brinton, Roberta Diaz

Publication type:

Letter

Sex-specific associations of serum testosterone with gray matter volume and cerebral blood flow in midlife individuals at risk for Alzheimer's disease.

Published in:

PLoS ONE, 2025, v. 20, n. 1, p. 1, doi. 10.1371/journal.pone.0317303

By:

Nerattini, Matilde;
Williams, Schantel;
Andy, Caroline;
Carlton, Caroline;
Zarate, Camila;
Boneu, Camila;
Fauci, Francesca;
Ajila, Trisha;
Jett, Steven;
Battista, Michael;
Pahlajani, Silky;
Berti, Valentina;
Andrews, Randolph;
Matthews, Dawn C.;
Dyke, Jonathan P.;
Brinton, Roberta Diaz;
Mosconi, Lisa

Publication type:

Article

Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer's disease patients.

Published in:

Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2024, v. 10, n. 3, p. 1, doi. 10.1002/trc2.12490

By:

Matthews, Dawn C.;
Kinney, Jefferson W.;
Ritter, Aaron;
Andrews, Randolph D.;
Toledano Strom, Erin N.;
Lukic, Ana S.;
Koenig, Lauren N.;
Revta, Carolyn;
Fillit, Howard M.;
Zhong, Kate;
Tousi, Babak;
Leverenz, James B.;
Feldman, Howard H.;
Cummings, Jeffrey

Publication type:

Article

Development, initial validation, and application of a visual read method for [<sup>18</sup>F]MK‐6240 tau PET.

Published in:

Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2023, v. 9, n. 1, p. 1, doi. 10.1002/trc2.12372

By:

Shuping, Joanna L.;
Matthews, Dawn C.;
Adamczuk, Katarzyna;
Scott, David;
Rowe, Christopher C.;
Kreisl, William C.;
Johnson, Sterling C.;
Lukic, Ana S.;
Johnson, Keith A.;
Rosa‐Neto, Pedro;
Andrews, Randolph D.;
Van Laere, Koen;
Cordes, Lindsay;
Ward, Larry;
Wilde, Claire L.;
Barakos, Jerome;
Purcell, Derk D.;
Devanand, Davangere P.;
Stern, Yaakov;
Luchsinger, Jose A.

Publication type:

Article

Measurement of neurodegeneration using a multivariate early frame amyloid PET classifier.

Published in:

Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2022, v. 8, n. 1, p. 1, doi. 10.1002/trc2.12325

By:

Matthews, Dawn C.;
Lukic, Ana S.;
Andrews, Randolph D.;
Wernick, Miles N.;
Strother, Stephen C.;
Schmidt, Mark E.

Publication type:

Article

Exploratory imaging outcomes of a phase 1b/2a clinical trial of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: Structural effects and functional connectivity outcomes.

Published in:

Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2022, v. 8, n. 1, p. 1, doi. 10.1002/trc2.12258

By:

Raikes, Adam C.;
Hernandez, Gerson D.;
Matthews, Dawn C.;
Lukic, Ana S.;
Meng Law;
Yonggang Shi;
Schneider, Lon S.;
Brinton, Roberta D.

Publication type:

Article

Rasagiline effects on glucose metabolism, cognition, and tau in Alzheimer’s dementia.

Published in:

Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2021, v. 7, n. 1, p. 1, doi. 10.1002/trc2.12106

By:

Matthews, Dawn C.;
Ritter, Aaron;
Thomas, Ronald G.;
Andrews, Randolph D.;
Lukic, Ana S.;
Revta, Carolyn;
Kinney, Jefferson W.;
Tousi, Babak;
Leverenz, James B.;
Fillit, Howard;
Kate Zhong;
Feldman, Howard H.;
Cummings, Jeffrey

Publication type:

Article